Sports / Entertainment

Thor Announces Preliminary Sales for Quarter, Backlog, Cash and Investments PR Newswire (press release) 2, 2011 /PRNewswire/ — Thor Industries, Inc. (NYSE: THO) announced today preliminary sales and backlog for the quarter and three months ended October 31, 2011. Preliminary consolidated sales in the quarter were $ 673670000, up 11% from $ 606684000 last … and more »

topic:thor – Google News

Thor Announces Preliminary Sales for Quarter, Fiscal Year; Backlog, Cash and … PR Newswire (press release) 2, 2011 /PRNewswire/ — Thor Industries, Inc. (NYSE: THO) announced today preliminary sales and backlog for the quarter and twelve months ended July 31, 2011. Sales in the quarter were $ 769 million, up 16% from $ 664 million last year. … and more »

topic:thor – Google News

msnbc.com

J.Lo, Tyler cash in on 'Idol' Toronto Sun Every year the producers of American Idol pride themselves on how they're giving aspiring young singers the break of a lifetime, and a revamped Season 10 was no exception. So whose career will reap the biggest benefit from all the Idolatry? … Celebrity Scandal: Scotty McCreery denies dating Lauren Alaina, totally?JohnJohnSaidIt.com Scotty McCreery & Laura Alaina: City of Hope Softball StarsThe Gossip Girls Lauren Alaina, Scotty McCreery make their Grand Ole Opry debutZap2it.com (blog) Examiner.com -Reality TV Magazine -antiMUSIC.com all 163 news articles »

topic:american_idol – Google News

Cash goes to Japan stocks, broad equities lose -EPFR
NEW YORK, March 18 (Reuters) – Japanese equity funds tookin fresh cash in the week ended March 16 even as stocks inTokyo plunged after last week’s devastating earthquake, a sharpcontrast to overall …

Read more on Reuters UK Focus via Yahoo! UK & Ireland Finance

More biotechs look to markets for cash
After two of the bleakest years for biotechnology companies going public, the sector has staged something of a revival in 2010.

Read more on San Diego Union-Tribune

Electric Vehicle Companies Tap Silicon Valley Cash
As hard times have fallen on America’s Rust Belt, a new region is hoping to give Detroit a run for its money. Clean-tech entrepreneurs in Silicon Valley are investing in the emerging electric car industry. And Google is among the investors.

Read more on NPR

Meet the Cash Kings of Software
These companies are rolling in greenbacks.

Read more on The Motley Fool

Product Description
This digital document is an article from San Diego Business Journal, published by Thomson Gale on July 16, 2007. The length of the article is 1001 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.
Author: Katie Weeks
Publication: San Diego Business Journal (Magazine/Journal)
Date: July 16, 2007
Publisher: Thomson Gale
Volume: 28 Issue: 29 Page: 1(2)

Distributed by Thomson Gale

Mergers, acquisitions leading ‘exit strategy’ for biotech companies: investors: initial public offerings not always best way to cash out.: An article from: San Diego Business Journal

Product Description
The biotechnology industry is growing rapidly. Every year increasing numbers of life science graduates enter the workforce, more researchers seek to commercialize their research findings, and growing numbers of biotechnology-minded business students and business professionals seek to apply their skills and knowledge to biotechnology. Some of these biotechnology workers enter existing companies, whereas others start their own companies. Regardless of their education, training, or the nature of their work, this growing constituency is challenged to learn how to operate within the biotechnology industry, while continually monitoring and managing the implications of changes in the underpinning fundamentals.

Those operating within the industry – whether in biotechnology companies or in associated supportive roles – are constantly challenged to keep abreast of industry developments and understand their significance. Seeking to meet the need to understand how to practice the business of biotechnology, these best practices provide a framework upon which to understand critical issues in biotechnology business development. Experts from a wide range of disciplines have composed best practices based on their experiences and expertise, creating a vital toolbox covering a broad spectrum of topics. These best practices will enable you develop a better understanding of the key elements in these operations and empower you to better manage their implementation.

Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property

Product Description
This digital document is an article from Fairfield County Business Journal, published by Westfair Communications, Inc. on January 29, 2001. The length of the article is 811 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Biotech companies cash in on ‘Year of the Genome’.
Author: Penni Crabtree
Publication: Fairfield County Business Journal (Magazine/Journal)
Date: January 29, 2001
Publisher: Westfair Communications, Inc.
Volume: 40 Issue: 5 Page: 3

Distributed by Thomson Gale

Biotech companies cash in on ‘Year of the Genome’.: An article from: Fairfield County Business Journal